Investment
Features
FeesSafety
Academy
More
Pluang+

Filament shareholders approve acquisition by Red Light Holland, deal expected to close April 29, 2026.

Company Fundamentals
27 Apr 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Filament Health shareholders have overwhelmingly approved a plan of arrangement for Red Light Holland to acquire all outstanding shares of Filament. The approval vote reached nearly 100%, meeting all regulatory and minority shareholder requirements. Upon closing, expected around April 29, 2026, Filament shareholders will own about 30% of Red Light shares. The deal includes issuance of up to 182 million Red Light shares as consideration, subject to resale restrictions. Final court approval is pending, marking a significant step in expanding Red Light's presence in the legal psychedelic sector through Filament's natural psychedelic drug development platform.

More News (TRIP)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App